Serum dipeptidyl peptidase 4: a predictor of disease activity and prognosis in inflammatory bowel disease

Background: Serum dipeptidyl peptidase 4 (DPP-4) has drawn particular interest as a biomarker in inflammatory bowel disease (IBD), as this protease inactivates several peptides that participate in the inflammatory cascade. Methods: Two prospectively recruited cohorts consisting of 195 patients (101...

Full description

Bibliographic Details
Main Author: Pinto-Lopes, Pedro (author)
Other Authors: Afonso, Joana (author), Pinto-Lopes, Rui (author), Rocha, Catia (author), Lago, Paula (author), Goncalves, Raquel (author), Sousa, Helena Tavares (author), Macedo, Guilherme (author), Dias, Claudia Camila (author), Magro, Fernando (author)
Format: article
Language:eng
Published: 2021
Subjects:
Biomarkers
Dipeptidyl peptidase 4
Inflammatory bowel disease
Gastroenterology & Hepatology
Online Access:http://hdl.handle.net/10400.1/15679
Country:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/15679

Internet

http://hdl.handle.net/10400.1/15679

Similar Items